查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球尼帕病毒感染檢測市場
市場調查報告書
商品編碼
1380261

2023-2030 年全球尼帕病毒感染檢測市場

Global Nipah Virus Infection Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 225 Pages | 商品交期: 2-3個工作天內

價格

細分市場前景

全球尼帕病毒感染檢測市場按檢測類型、樣本和最終用戶進行細分。根據測試類型，市場分為基於 RT PCR 的試劑盒和 ELISA 試劑盒。根據樣本，市場分為血清或血漿、唾液和咽拭子、尿液等。此外，依市場細分為醫院、研究機構、診斷中心等。

ELISA 試劑盒子部分預計將為全球尼帕病毒感染檢測市場做出重大貢獻

在檢測類型中，ELISA試劑盒子細分市場預計將在全球尼帕病毒感染檢測市場中佔據相當大的佔有率。該細分市場的成長歸因於 ELISA 測試採用率的增加。由於 ELISA 已被證明是尼帕病毒檢測的可行技術，因此有可能擴大該測試在臨床和公共衛生環境中的使用。 ELISA等經濟有效的診斷技術可用於大規模的流行病學調查。據美國國立衛生研究院（gov.）2022年9月稱，ELISA是一種有效、安全且具有成本效益的診斷工具，可用於大規模流行病學調查中檢測尼帕病毒。 IgM 和 IgG ELISA 測試還可以幫助為公共衛生干涉措施提供資訊。此外，與美國疾病管制與預防中心 (CDC) 的參考測試相比，開發的抗 NiV IgM 和 IgG ELISA 表現出 99.28% 的特異性和 100% 的靈敏度。抗尼帕 IgM 和 IgG ELISA 檢測顯示陰性預測值分別為 100%，陽性預測值分別為 90% 和 93.94%，測試準確度為 99.33%。

區域展望

全球尼帕病毒感染檢測市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國） 、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。

亞太地區全球尼帕病毒感染檢測市場預計將以顯著的CAGR成長

在所有地區中，亞太地區預計在預測期內將以可觀的CAGR成長。區域成長歸因於測試需求的增加。喀拉拉邦報告的病例強調了擁有準確且廣泛可用的尼帕病毒診斷程序的重要性。確診病例後，還需要進行檢測、接觸者追蹤和疫情管理。

據世界衛生組織（WHO）稱，2023年10月，自9月12日以來，已檢測了387份樣本，結果出現6例尼帕病毒感染陽性病例和381例陰性樣本。此外，據喀拉拉邦政府稱，2023年9月12日至15日期間報告了六起實驗室確診的尼帕病毒感染病例，其中兩人死亡。喀拉拉邦科澤科德地區記錄的每起確診病例均涉及年齡在 9 歲至 45 歲之間的男性。

市場參與者展望

服務尼帕病毒感染檢測市場的主要公司包括： Creative Biogene、江蘇Bioperfectus Technologies Co., Ltd.、Molbio Diagnostics Pvt.。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布）為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023 年 9 月，喀拉拉邦從印度醫學研究委員會 (ICMR) 獲得了單株抗體，並在該州中心設立了一個行動實驗室，以對抗正在爆發的尼帕病毒。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球尼帕病毒感染檢測市場中營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按測試類型分類的全球尼帕病毒感染測試市場
    • 基於 RT PCR 的試劑盒
    • ELISA 試劑盒
  • 按樣本類型分類的全球尼帕病毒感染檢測市場
    • 血清或血漿
    • 唾液和咽拭子
    • 尿
    • 其他（腦脊髓液（CSF）、呼吸道分泌物和環境樣本）
  • 全球尼帕病毒感染檢測市場（按最終用戶）
    • 醫院
    • 研究機構
    • 診斷中心
    • 其他（非政府組織 (NGO)、緊急應變小組、公共衛生當局）

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Creative Biogene.
  • Creative Diagnostics
  • Indian Council of Medical Research-National Institute of Virus
  • Jiangsu Bioperfectus Technologies Co., Ltd
  • Liferiver Bio-Tech Corp.
  • Molbio Diagnostics Pvt. Ltd.
  • MyBioSource
  • Pirbright researchers
  • YouSeq Ltd.
Product Code: OMR2027811

Title: Global Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report by Test (RT PCR Based Kits, and ELISA Kits), by Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), and by End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others),Forecast Period (2023-2030).

Global Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the Forecast Period (2023-2030). The market's growth is attributed to the growing incidence of Nipah virus infection across the globe. NiV can be passed from infected animals (such as pigs or bats) or their bodily fluids to individuals through contact. It involves fluids including blood, urine, and saliva. According to the National Institute of Health, in March 2023, Encephalitis and NiV infection are connected (inflammation of the brain). After exposure and a period lasting from 5 to 14 days, the illness starts with a fever and headache that persist for 3-14 days. Lethargy, disorientation, and confusion may then follow. Within 24-48 hours, these signs and symptoms may progress to a coma. Early in their infections, some individuals may experience respiratory issues, and 50% of those who exhibited severe neurological symptoms additionally had pulmonary symptoms. Transmission of NiV may occur through contact with infected animals such as pigs or bats, or their body fluids (such as saliva, urine, or blood). During the first recorded NiV outbreak, people contracted the virus through close contact with sick pigs. The NiV strain found during that outbreak seemed to have initially spread among bats, then to pigs, and finally to pig populations.

Segmental Outlook

The global Nipah virus infection testing market is segmented on the test type, sample, and end-user. Based on the test type, the market is sub-segmented into RT PCR-based kits, and ELISA Kits. Based on the sample, the market is sub-segmented into blood serum or plasma, saliva and throat swabs, urine, and others. Furthermore, based on the market is sub-segmented into hospitals, research institutions, diagnostic centers, and others.

The ELISA Kits Sub-Segment is Anticipated to Contribute Significantly to the Global Nipah Virus Infection Testing Market

Among the test types, the ELISA Kits sub-segment is expected to hold a considerable share of the global Nipah virus infection testing market. The segmental growth is attributed to the increasing ELISA testing adoption. There is potential for an expansion in the use of the tests in clinical and public health settings as ELISA has proven to be a viable technique for Nipah virus detection. Economical and effective diagnostic technologies such as ELISA can be utilized in large-scale epidemiological investigations. According to the National Institute of Health (gov.), in September 2022, ELISA is an effective, safe, and cost-efficient diagnostic tool that can be used to detect Nipah virus in large-scale epidemiological investigations. IgM and IgG ELISA tests can also help inform public health interventions. Furthermore, in comparison to a reference test from the Centers for Disease Control and Prevention (CDC), US, the developed anti-NiV IgM and IgG ELISAs demonstrated a specificity of 99.28% and a sensitivity of 100%. Anti-Nipah IgM and IgG ELISA assays showed 100% negative predictive value and 90% and 93.94% positive predictive value, respectively, with test accuracy of 99.33%.

Regional Outlook

The global Nipah virus infection testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nipah Virus Infection Testing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing demand for testing. The reported cases in Kerala emphasize the significance it is to having accurate and widely available diagnostic procedures for the Nipah virus. Testing for diagnosis, contact tracing, and epidemic management are all required after cases are confirmed.

According to the World Health Organization (WHO), in October 2023, since 12 September, 387 samples have been tested, resulting in six positive cases of Nipah virus infection and 381 negative samples. Furthermore, six laboratory-confirmed cases of Nipah virus infection, including two fatalities, were reported between September 12 and September 15, 2023, according to the Kerala State Government. Males between the ages of 9 and 45 were involved in every confirmed instance, which was recorded in Kerala's Kozhikode district.

Market Players Outlook

The major companies serving the Nipah virus infection testing market include: Creative Biogene, Jiangsu Bioperfectus Technologies Co., Ltd., Molbio Diagnostics Pvt. Ltd., and YouSeq Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2023, Kerala received monoclonal antibodies from the Indian Council of Medical Research (ICMR) and to combat the ongoing Nipah virus outbreak, a mobile laboratory has been set up at the center of the state.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Nipah virus infection testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 1.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nipah Virus Infection Testing Market by Test Type
    • 4.1.1. RT PCR based kits
    • 4.1.2. ELISA Kits
  • 4.2. Global Nipah Virus Infection Testing Market by Sample Type
    • 4.2.1. Blood Serum or Plasma
    • 4.2.2. Saliva and Throat Swabs
    • 4.2.3. Urine
    • 4.2.4. Others (Cerebrospinal Fluid (CSF), Respiratory Secretions, and Environmental Samples)
  • 4.3. Global Nipah Virus Infection Testing Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Research Institutions
    • 4.3.3. Diagnostic Centers
    • 4.3.4. Others (Non-Governmental Organizations (NGOs), Emergency Response Teams, Public Health Authorities)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Creative Biogene.
  • 6.2. Creative Diagnostics
  • 6.3. Indian Council of Medical Research-National Institute of Virus
  • 6.4. Jiangsu Bioperfectus Technologies Co., Ltd
  • 6.5. Liferiver Bio-Tech Corp.
  • 6.6. Molbio Diagnostics Pvt. Ltd.
  • 6.7. MyBioSource
  • 6.8. Pirbright researchers
  • 6.9. YouSeq Ltd.

LIST OF TABLES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY TEST TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY SAMPLE, 2022 VS 2030 (%)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. LATIN AMERICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. MIDDLE EAST AND AFRICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)